Form 4 for FBIO Fortress Biotech, Inc.
Accepted 2026-03-20 00:00:00 ET · period of report 2026-03-18 · accession 0001038977-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-20 | 2026-03-18 | FBIO | WEISS MICHAEL S | Executive Vice COB, Dir | A - Grant | $0.00 | +475.4K | 2.28M | +26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | common stock, par value $0.001 | 2026-03-18 | A | A | 475,424 | $0.00 | 2,276,562 | D | — | — | (F1) The Reporting Person was granted 475,424 restricted shares pursuant to the Issuer's Long-Term Incentive Plan on March 18, 2026. |